Dymicron, the company developing the Triadyme-C cervical disc, added Peter Wehrly to its board of directors, according to a Feb. 19 news release.
Mr. Wehrly has extensive experience in the medtech industry including president of Premia Spine’s U.S. business, CEO of Vivex Biologics and multiple leadership roles within Medtronic.
“Dymicron’s Triadyme-C technology represents a true leap forward in motion preservation, combining advanced biomechanics with a bearing surface that addresses longstanding wear-debris challenges in cervical arthroplasty,” he said in the release. “The company’s commitment to rigorous clinical validation and global commercialization strongly aligns with my professional focus. I look forward to supporting the leadership team as Dymicron advances toward PMA approval and broadens its global impact.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
